Thermo Fisher Scientific (TMO) Other Non Operating Income (2009 - 2026)

Thermo Fisher Scientific has reported Other Non Operating Income for 18 years, with the latest figure at $31.0 million in Q2 2026.

• Other Non Operating Income for Q2 2026 came in at $31.0 million, up 263.16% year-over-year; the trailing twelve-month figure through Jun 2026 was $26.0 million (up 244.44% YoY), and the FY2025 annual result was -$12.0 million, down 200.0% from the prior year.
• Other Non Operating Income rose to $31.0 million in Q2 2026, from -$9.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $35.0 million in Q4 2022 and troughed at -$163.0 million in Q2 2022.
• A 5-year average of -$8.6 million and a median of $3.0 million in 2025 frame the typical range for Other Non Operating Income.
• The widest annual swing landed in 2022, when Other Non Operating Income surged 1033.33%; it then tumbled 480.0% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $35.0 million in 2022, then tumbled by 194.29% to -$33.0 million in 2023, then jumped by 142.42% to $14.0 million in 2024, then tumbled by 57.14% to $6.0 million in 2025, then surged by 416.67% to $31.0 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $31.0 million in Q2 2026, -$9.0 million in Q1 2026, and $6.0 million in Q4 2025.